SEYE Share Price | Smart Eye AB Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Smart Eye AB with Similar Stocks

Sedana Medical AB Bactiguard Holding AB Genovis AB

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Flat results in Dec 25

DEBTORS TURNOVER RATIO(HY) Lowest at 2.34 times
DEBT-EQUITY RATIO (HY) Highest at 15.3 %
INTEREST(Q) Highest at SEK 19.24 MM

Risky -

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 2,149 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.15

Return on Equity

-13.34%

Price to Book

1.66

Revenue and Profits:

Net Sales:

122 Million

(Quarterly Results - Dec 2025)

Net Profit:

-50 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-29.68%

6 Months

-34.7%

1 Year

10.75%

2 Years

-38.38%

3 Years

16.72%

4 Years

-46.98%

5 Years

-71.23%

Smart Eye AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

44.04%

EBIT Growth (5y)

-152.04%

EBIT to Interest (avg)

-134.27

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.05

Sales to Capital Employed (avg)

0.22

Tax Ratio

10.66%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.31

EV to EBIT

-14.70

EV to EBITDA

-63.71

EV to Capital Employed

2.22

EV to Sales

9.17

PEG Ratio

Dividend Yield

ROCE (Latest)

-15.09%

ROE (Latest)

-15.27%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 21.93% vs 9.86% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 24.77% vs -148.24% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "122.30",
          "val2": "100.30",
          "chgp": "21.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.30",
          "val2": "-15.60",
          "chgp": "140.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.20",
          "val2": "2.40",
          "chgp": "700.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-49.50",
          "val2": "-65.80",
          "chgp": "24.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-290.50%",
          "val2": "-598.70%",
          "chgp": "30.82%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.72% vs 17.47% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 25.00% vs -205.17% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "403.70",
          "val2": "355.00",
          "chgp": "13.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.70",
          "val2": "-82.70",
          "chgp": "103.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "31.30",
          "val2": "4.40",
          "chgp": "611.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-172.80",
          "val2": "-230.40",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-410.40%",
          "val2": "-706.10%",
          "chgp": "29.57%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

122.30

100.30

21.93%

Operating Profit (PBDIT) excl Other Income

6.30

-15.60

140.38%

Interest

19.20

2.40

700.00%

Exceptional Items

0.00

Consolidate Net Profit

-49.50

-65.80

24.77%

Operating Profit Margin (Excl OI)

-290.50%

-598.70%

30.82%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 21.93% vs 9.86% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 24.77% vs -148.24% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

403.70

355.00

13.72%

Operating Profit (PBDIT) excl Other Income

2.70

-82.70

103.26%

Interest

31.30

4.40

611.36%

Exceptional Items

0.00

Consolidate Net Profit

-172.80

-230.40

25.00%

Operating Profit Margin (Excl OI)

-410.40%

-706.10%

29.57%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 13.72% vs 17.47% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 25.00% vs -205.17% in Dec 2024

All Annual Results

Company CV

About Smart Eye AB

Smart Eye AB

Pharmaceuticals & Biotechnology

Smart Eye AB (publ) is a Sweden-based company engaged in the machine vision system development. The Company focuses on designing a real-time eyelid and head tracking technology. The Company's activities are divided into two areas: Applied solutions and Research instruments. The Applied solutions area offers tracking technology for automotive industry, including AntiSleep, an integrated camera and software, which measures driver head pose, gaze direction and eyelid closure, and Blackbird, a compact camera system for tracking and measuring human eye and head movements. The Research instruments area provides equipment for tracking, measuring and analyzing human eye movements in various industries, such as aerospace, aviation, psychology, communication, neuroscience, medicine and clinical research.

Company Coordinates

Company Details

Forsta Langgatan 28B , GOTEBORG None : 413 27

Tel: 46 31 606160

https://smarteye.se/

Registrar Details